Get startedLog in
    Picture of 3D Medicines logo

    1244 — 3D Medicines Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for 3D Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSARSARSARS
    Standards:
    IFRS
    IFRS    		—
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-635-1,462-1,052-562-199
    Depreciation
    Amortisation
    Non-Cash Items3321,1127592828.98
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital21.8-39.9-7.35111-45.4
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Cash from Operating Activities-278-377-279-144-211
    Capital Expenditures-11.1-44.9-54-6.32-1.46
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-9.33-54-188-18119.4
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-20.5-98.9-242-18818
    Financing Cash Flow Items-18.5309-24.211.5-0.753
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities607840408305-33.9
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash302360-77.6-30.3-222